Global market valuation was derived through revenue mapping and procedure volume analysis across therapeutic equipment and software segments. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Product mapping across electrotherapy equipment (TENS, EMS, IFC), therapeutic ultrasound, combination therapy devices, traction units, laser therapy, cryotherapy/hydrotherapy systems, robotic rehabilitation devices, and practice management/telehealth software platforms
Analysis of reported and modeled annual revenues specific to physical therapy equipment portfolios
Coverage of manufacturers representing 72-78% of global market share in 2024
Extrapolation using bottom-up (procedure volume × ASP by country/region across hospital, clinic, and home care settings) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations for equipment, accessories, and software deployment models (on-premise, web-based, cloud-based)